Category: Biosimilars
Global Biosimilars
-
Filgrastim Biosimilars Global Market Report 2024
... Pharmacy; Retail Pharmacy; Online Pharmacy Covering: Teva Pharmaceutical Industries Ltd; Novartis International AG; Biocon Limited; Intas Biopharmaceuticals; Dr. Reddy's Laboratories Filgrastim Biosimilars Global Market Report 2024 from The Business Research Company provides strategists, marketers and ... Read More
-
Biosimilars Global Market Report 2024
... Deficiency; Infectious Diseases Covering: Amgen; Pfizer; Novartis AG; Samsung Bioepis Co., Ltd.; Viatris Biosimilars Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need ... Read More
-
Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2024
... Rheumatoid Arthritis; Ulcerative Colitis; Ankylosing Spondylitis; Plaque Psoriasis Covering: Biogen; Novartis (Sandoz); Pfizer; Amgen; Celltrion Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Global Biosimilars - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... billion by 2029, growing at a CAGR of 18.32% during the forecast period (2024-2029). The impact of COVID-19 on the biosimilars market may be significant, and it has imposed a great challenge on the pharmaceutical ... Read More
-
Biologics CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... billion by 2029, growing at a CAGR of 12.78% during the forecast period (2024-2029). With an increasing number of companies within the pharmaceutical sector considering outsourcing services, the demand for services from contract manufacturing and ... Read More
-
Bioprocess Analyzers Market (Product: Instruments and Consumables & Accessories: and Application: Antibiotics, Recombinant Proteins, Biosimilars, and Monoclonal Antibodies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Report TMR’s report on the global bioprocess analyzers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period ... Read More
-
Oral Biologics & Biosimilar Drugs Global Market Report 2024
... Psoriasis3) By Molecule Type: Vaccines; Proteins & Peptides; Monoclonal Antibodies4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Novartis International AG; Rani Therapeutics Holdings Inc.; Eli Lilly and Company; AstraZeneca plc; Novo Nordisk A/S ... Read More
-
Biosimilar Growth Hormones Global Market Report 2024
... Hospital And Retail Pharmacy; Online Pharmacy/ePharmacy; Specialty ClinicsCovering: Amega Biotech; Biosidus S.A.; Eli Lilly and Company; Ferring Pharmaceuticals; Genetech Inc. Biosimilar Growth Hormones Global Market Report 2024 from The Business Research Company provides strategists, marketers ... Read More
-
Biosimilar Monoclonal Antibodies Global Market Report 2024
... Inc.; Coherus BioSciences; Biocon Limited Biosimilar Monoclonal Antibodies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report ... Read More
-
Biosimilar Interleukins Global Market Report 2024
... Pharmacies; Clinics; Research InstitutesCovering: Mabpharm Limitied; Gedeon Richter plc; Bio-Thera Solutions Ltd.; Sorrento Therapeutics; Sunshine Guojian Pharmaceutical Biosimilar Interleukins Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with ... Read More
-
Oncology Biosimilars Global Market Report 2024
... Cancer 3) By Distribution Type: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy Covering: Biocon Biologics Limited; Celltrion Inc.; Dr. Reddy's Laboratories Ltd.; Intas Pharmaceuticals Ltd.; STADA Arzneimittel AG Oncology Biosimilars Global Market Report 2024 from The ... Read More
-
Biosimilar Hormones Global Market Report 2024
... Online Pharmacy/pharmacy; Specialty ClinicsCovering: Teva Pharmaceutical Industries Ltd.; Gedeon Richter Plc.; Intas Pharmaceuticals Ltd.; Biocon Limited; Mylan Biosimilar Hormones Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with ... Read More
-
Biosimilar Lymphocyte Modulator Global Market Report 2024
... 3) Distribution Channel: Online Pharmacies; direct to consumerCovering: Pfizer Inc.; Biogen Inc.; Celltrion Inc.; Genentech Inc.; Novartis AG Biosimilar Lymphocyte Modulator Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Erythropoietin Drugs Market Forecasts to 2030 – Global Analysis By Type (Biosimilars and Biologics), Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa and Other Products), Distribution Channel, Application, End User and By Geography
... Erythropoietin Drugs Market is accounted for $10.7 billion in 2023 and is expected to reach $25.6 billion by 2030 growing at a CAGR of 13.2% during the forecast period. Erythropoietin drugs are a class of ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2024-2032
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2024-2032 The global PEGylated proteins market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market ... Read More
-
Insulin biosimilars Global Market Report 2024
... Retail Pharmacies; Online Pharmacies4) By End User: Hospitals; Ambulatory Surgical CentersCovering: Eli Lilly and Company; Boehringer Ingelheim GmbH; Merck & Co Inc.; Pfizer Inc.; Biocon Ltd. Insulin biosimilars Global Market Report 2024 from The Business ... Read More
-
Biobetters Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Biobetters Market has demonstrated robust growth from 2024 to 2031. This growth trajectory is set to continue, with an anticipated steady CAGR of 10% expected between 2024 and 2031. In 2024, the global Biobetters Market ... Read More
-
Global Insulin Biosimilars Market - 2023-2030
... period 2023-2030. Biosimilars are equivalent to a reference biologic drug and are developed after the patent on the concerned biologic drug has passed. Biosimilar insulin is a biological replica of an actual insulin and there ... Read More
-
Bioprocess Technology Market by Product (Consumables & Accessories, Instruments), Application (Antibiotics, Biosimilar, Monoclonal Antibodies), End-User - Global Forecast 2024-2030
... reach USD 23.70 billion in 2024, at a CAGR 12.39% to reach USD 47.95 billion by 2030. Global Bioprocess Technology Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Bioprocess Technology ... Read More
-
Oncology Biosimilars Market by Application (Cancer Treatment Drugs, Supportive Care Drugs), End-User (Hospitals, Retail Pharmacies) - Global Forecast 2024-2030
... reach USD 5.48 billion in 2024, at a CAGR 18.11% to reach USD 14.91 billion by 2030. Global Oncology Biosimilars Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Oncology Biosimilars ... Read More
-
Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Global Forecast 2024-2030
... at USD 9.88 billion in 2023 and expected to reach USD 10.59 billion in 2024, at a CAGR 7.44% to reach USD 16.35 billion by 2030. Global Biologics Contract Development & Manufacturing Organization MarketBiologics contract ... Read More
-
Bioprocess Analyzers Market by Type (Consumables & Accessories, Instruments), Application (Antibiotics, Biosimilars, Recombinant Proteins), End User - Global Forecast 2024-2030
... to reach USD 581.42 million in 2024, at a CAGR 11.54% to reach USD 1,121.04 million by 2030. Global Bioprocess Analyzers Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Bioprocess ... Read More
-
Biosimilars Market by Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Indication (Autoimmune Diseases, Blood Disorders, Chronic Diseases), Manufacturing - Global Forecast 2024-2030
... 2023 and expected to reach USD 49.91 billion in 2024, at a CAGR 23.31% to reach USD 176.48 billion by 2030. Global Biosimilars Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Protein Engineering Market by Type (Coagulation Factors, Colony-Stimulating Factors, Erythropoietins), Product & Service (Consumables, Instruments, Software & Services), Technology, End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 4.16 billion in 2024, at a CAGR 10.21% to reach USD 7.49 billion by 2030. Global Protein Engineering Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Erythropoietin Stimulating Agents Market by Type (Darbepoetin Alfa, Epoetin Alfa, Epoetin Beta), Application (Anemia, Antiretroviral Treatment, Cancer Chemotherapy) - Global Forecast 2024-2030
... 2023 and expected to reach USD 10.32 billion in 2024, at a CAGR 5.64% to reach USD 14.45 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Erythropoietin Stimulating ... Read More
Research Assistance
